Gleneagles Hospital helps brain cancer patient to recover through indigenous CAR-T cell therapy
A 49-year-old patient with primary central nervous system lymphoma was successfully treated at Gleneagles Hospital in Chennai using indigenous CAR-T cell therapy. This advanced treatment, known as NexCAR19, represents a significant milestone in domestic cancer care.
Why it matters
The successful application of indigenous CAR-T therapy demonstrates India's growing capability in high-end medical biotechnology and personalized cancer treatment.
A 49-year-old patient who was diagnosed with a rare life-threatening form of brain lymphoma was successfully treated using advanced and indigenous cell therapy at a private hospital in Chennai.
The article is a straightforward medical report on a successful clinical outcome.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in